FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†

Bas W.G. van Rhijn, Laura S. Mertens, Roman Mayr, Peter J. Boström, Francisco X. Real, Ellen C. Zwarthoff, Joost L. Boormans, Cheno Abas, Geert J.L.H. van Leenders, S. A. Gotz, Katrin Hippe, Simone Bertz, Y. Neuzillet, Joyce Sanders, Annegien Broeks, Michiel S. van der Heijden, Michael A.S. Jewett, Mirari Márquez, Robert Stoehr, Alexandre R. Zlotta, Markus Eckstein, Yanish Soorojebally, Hossain Roshani, Maximilian Burger, Wolfgang Otto, François Radvanyi, Nanor Sirab, Damien Pouessel, Bernd Wullich, Theodorus van der Kwast, Núria Malats, Arndt Hartmann, Yves Allory, Tahlita C.M. Zuiverloon